Article
Alterations in osteopontin modify muscle size in females in both humans and mice.
Medicine and science in sports and exercise - 1 Jun 2013
Hoffman Eric P, Gordish-Dressman Heather, McLane Virginia D, Devaney Joseph M, Thompson Paul D, Visich Paul, Gordon Paul M, Pescatello Linda S, Zoeller Robert F, Moyna Niall M, Angelopoulos Theodore J, Pegoraro Elena, Cox Gregory A, Clarkson Priscilla M
Abstract excerpt
PURPOSE: An osteopontin (OPN; SPP1) gene promoter polymorphism modifies disease severity in Duchenne muscular dystrophy, and we hypothesized that it might also modify muscle phenotypes in healthy volunteers. METHODS: Gene association studies were carried out for OPN (rs28357094) in the FAMuSS cohort (n = 752; mean ± SD age = 23.7 ± 5.7 yr). The phenotypes studied included muscle size (MRI), strength, and response...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
